JP Morgan analyst Julia Qin downgrades Invitae (NYSE:NVTA) from Neutral to Underweight.
Exagen Inc. And Johns Hopkins University Announce License Agreement For Novel Patented Lupus Nephritis Biomarkers
Exagen Inc. (NASDAQ:XGN), a leading provider of autoimmune testing solutions, and Johns Hopkins University jointly announced today the execution of an exclusive license agreement. Exagen will focus on the